By MP McQueen | October 3, 2019
The Federal Trade Commission announced Thursday that it had demanded reports from six e-cigarette manufacturers about their sales, promotion and advertising practices.
New York Law Journal | Analysis
By Scott D. Locke | July 24, 2019
For the businesses that wish to push forward on this uncertain landscape, cautious and strategic marketing may be the best—although not risk free—course of action.
By Amanda Bronstad | June 18, 2018
A New York state court judge has refused to dismiss lawsuits against several opioid manufacturers in some of the first substantive rulings to come out of the barrage of cases brought by governments over the prescription painkillers.
By Meghana Shah, Brittany Cambre and Amber Unwala | May 18, 2018
While the proliferation of slack fill claims may concern food and beverage manufacturers, recent legal developments indicate that the viability of these claims may be short lived.
By Amanda Bronstad | April 24, 2018
Merck has moved to coordinate dozens of lawsuits brought over injuries allegedly caused by its shingles vaccine, Zostavax.
By Kristen Rasmussen | April 18, 2018
Jeremy Livianu comes to New York City-based Establishment Labs Holdings Inc. from Redwood City, California's Nevro Corp., where he built the legal department from scratch and helped take the company public.
By Andrew Denney | April 5, 2018
Pharmaceutical company McKesson Corp. and two of its subsidiaries engaged in a scheme to skim excess oncology drugs from prepackaged vials, a health care provider has alleged in a new complaint filed in Brooklyn federal court.
By Brian J. Malkin, Chair, NYSBA Food, Drug and Cosmetic Law Section | January 19, 2018
Brian J. Malkin, Chair of the NYSBA Food, Drug and Cosmetic Law Section writes: The Food, Drug and Cosmetic Law Section this year has focused its program in selecting topics of a cross-functional nature, as discussed below.
By Kristen Rasmussen | December 20, 2017
Boehringer Ingelheim Pharmaceuticals Inc. will pay $13.5 million to settle allegations by attorneys general in all 50 states and the District of Columbia that the company marketed some of its drugs for unapproved uses.
By Jason Grant | November 16, 2017
Allegations pleaded in the original complaint of Ada Damla Demir, who had been employed by Sandoz, a division of Novartis, sufficed to give defendants notice of the occurrences that led to the whistleblower claim.
Presented by BigVoodoo
The New York Law Journal honors attorneys and judges who have made a remarkable difference in the legal profession in New York.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Truly exceptional Bergen County New Jersey Law Firm is growing and seeks strong plaintiff's personal injury Attorney with 5-7 years plaintif...
Shipman is seeking an associate to join our Labor & Employment practice in our Hartford, New Haven, or Stamford office. Candidates shou...
Evergreen Trading is a media investment firm headquartered in NYC. We help brands achieve their goals by leveraging their unwanted assets to...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS